Keck Medicine of USC Lab (IMAGE)

University of Southern California - Health Sciences

Keck Medicine of USC Lab

Caption

Keck Medicine of USC physicians are participating in a clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.

Credit

Ricardo Carrasco III

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.